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Abstract:
Chronic use of methamphetamine (meth) disrupts cortical processing across
multiple cognitive domains including impulsivity, decision making and memory.
Our laboratory has consistently shown that extended access to contingent meth
self-administration reliably produces memory deficits in novel object recognition
(NOR) tasks designed to test the “what” component of episodic memory in a
rodent model. This type of memory is dependent on an intact function of the
perirhinal cortex (PRH). However, the ongoing role of the prefrontal cortex (PFC)
in this task and the directionality of communication between the PRH and the
PFC is not entirely understood. A set of four experiments were designed to
characterize the bi-directional connection between the PFC and the PRH during
the exploration of novel vs. familiar objects and whether the manipulation of the
circuit will restore recognition memory following chronic meth self-administration
(SA). Male and female rats were infused with retrograde GFP-tagged adenoassociated virus (AAV) in the PRH (Experiment 1) and the PFC (Experiment 2).
Three weeks later rats were tested for NOR with half the animals exploring two
familiar objects and half exploring a novel object. Brain tissue was processed for
co-labeled cells containing both GFP and c-Fos, an indicator of neuronal
activation. Rats spent more time exploring novel vs. familiar objects. During
novel object exploration, animals that explored novel objects had more colabeled cells that project from the PRH to the PFC, but not in cells that project
from PFC to the PRH. A dual viral approach was utilized in the second set of
viii

experiments to activate the PRH to PFC pathway following meth SA (Experiment
3) or inhibit the PRH to PFC pathway in meth naïve animals (Experiment 4). AAV
viral vectors containing CRE-dependent Designer Receptors Exclusively
Activated by Designer Drugs (DREADDs) were infused into the PRH while
retrograde AAV encoding CRE recombinase was infused into the PFC. A
recognition memory deficit was established in meth SA rats and restored through
activation of excitatory DREADDS (Experiment 3). In meth naïve animals a NOR
memory deficit was also induced by activation of inhibitory DREADDS within the
same circuit (Experiment 4). In conclusion, this data set suggests communication
from the PRH to the PFC directs novel object recognition.
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Chapter 1: Introduction
The use of psychoactive substances is as old as human civilizations. Such
substances have been integral parts of religious ceremonies, medicinal
treatments, and used by members of the population at large since prehistoric
times (1). As society has changed over millennia so has the relationship humans
have with these substances. The current concept of addiction as it is known
today was first described as early as the 17th century. According to current
pathological definitions, outlined in the DSM-V, substance use disorder is
classified as the “chronically relapsing, compulsive pattern of drug-taking” and
can vary in severity from mild to severe (2). Addiction can be thought of as a
cyclic pattern of thinking and behavior and can be further broken down into
stages (3). The three stages of the addiction cycle include an initial
binge/intoxication stage, followed by withdrawal/negative affect, where
unpleasant symptoms drive the user to the third stage of
preoccupation/anticipation or drug craving (3). Continual cycling can lead to a
substance use disorder (SUD) and can result in significant changes in the brain.
Section 1: Methamphetamine Use Disorder (MUD)
Methamphetamine, a psychostimulant, was synthesized from ephedrine by a
Japanese pharmacologist in the late 19th century. Since that time, the
population’s relationship with meth has been complicated. As our understanding
of action in the body and abuse potential has changed, so has the legality and
1

availability of the drug (4). Meth is predominantly metabolized in the liver and
excreted in urine. Depending on route of administration and individual variation,
meth can be found in the body 8-24 hours after use (5). Chronic use has not
been found to alter metabolism, thus increasing dosages among users is likely
due to changes in the brain. Since 2015, the number of users and overdoses has
increased worldwide. Driven by its’ relatively low cost and high purity levels, the
market for meth use has grown significantly in Asian countries with steady use
throughout North America (6,7). Clinical characteristics of MUD include altered
sleep patterns, paranoia, hallucinations, distractibility, motor hyperactivity,
psychosis, and cardiovascular problems (8). Indeed, long term use can lead to
cardio and neurovascular problems that often lead to premature death from
strokes (8). As a result, chronic meth use is associated with various individual
and societal burdens including health care, economic strains, and homelessness.
Meth dependence is further complicated by its’ high relapse rates following
sustained periods of abstinence (8).
Section 2: Effects of Chronic Meth Use on the Brain
Meth diffuses across the blood-brain barrier to enter the brain where it disrupts
the monoamine system, including dopamine, serotonin, and norepinephrine
neurotransmitter systems (9). Once inside neurons, this drug is responsible for
altering the release and production of monoamine molecules via multiple
mechanisms. Meth reverses monoamine transporters in the cell membrane that
are responsible for the removal of these molecules from the synaptic cleft. Meth
2

also reverses monoamine-containing vesicular transporters to stimulate
extensive premature monoamine release into the cytosol and synaptic cleft. Meth
can further interrupt the balance of monoamine metabolism and catabolism by
decreasing degradation proteins and increasing precursor molecules. Together
these changes result in an abundance of monoamine molecules in the synaptic
cleft and little within the cell and an impaired means of correcting the depletion
(10). The binding of vesicles to the cell membrane can also lead to the premature
or continual release of glutamate, the primary excitatory molecule in the brain,
into the synaptic cleft. When glutamate binds its receptors on the post-synaptic
cell, changes in Ca++, a secondary messenger, occur within the cell (11). This
stimulates downstream processes in the cell that can lead to stress on the
endoplasmic reticulum, the organelle responsible for the proper folding of
proteins necessary for normal cellular function. Combined these effects can lead
to excitotoxicity in the cell (12). Chronic methamphetamine use can induce other
types of stress in the cells of the brain as well. Reactive oxygen species are
common byproducts of dopamine auto-oxidation, which occurs as a result of an
overabundance of dopamine in the synaptic cleft and can lead to oxidative stress
(14). Meth can bind directly to microglial cells producing a rapid response and
release of cytokines from in the brain as a response. An abundance of cytokines
in the brain can lead to detrimental neuroinflammation (15,16). Such cellular
changes can have global impacts on how the brain functions.

3

Section 3: Memory Deficits Associated with MUD in Humans
Whereas small doses of stimulants have positive effects on human concentration
and alertness, large quantities resulting from chronic use can be detrimental to
the brain (17). Circuitry responsible for drug addiction overlaps with some limbic
and cortical regions involved in learning and memory. As a result of drug-related
changes, deficits in learning and memory have been shown in meth users and
understanding these deficits has become important for the overall treatment of
meth users. Clinical studies have shown that meth users show signs of cognitive
dysfunction in impulsivity, attention, as well as episodic and working memory
following a period of drug abstinence (18). Compared to healthy controls,
participants with methamphetamine use performed worse on tasks of attention,
episodic and spatial memory (19-21). Specifically, patients that had recently
relapsed following a period of drug abstinence performed more poorly than even
consistent users or abstinent users suggesting a crucial timepoint for therapies
(20, 21). Furthermore, meth users have shown deficiencies in metamemory or
the ability to know and understand memory capacity (23-25). Memory retention
inability impacts the ability of abstinent meth users to maintain daily functioning
behavior outside of drug use (24). As cognitive deficits have become more
understood, cognitive training has become a viable therapeutic strategy in
humans with methamphetamine addiction (23-26). The deficits in executive
function and memory are likely contributing factors to the high relapse potential
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seen in chronic users of meth and could therefore be potential targets for new
behavioral or pharmacological therapies.
Section 4: Brain Regions involved in Episodic Memory
Understanding the brain regions involved in different neuronal processes is
essential to how we interpret when things have changed from baseline. The
neuronal substrate for memory has, for many years, been attributed to
hippocampal function (27). Anatomically the hippocampus is connected to
several other brain regions. These regions include several cortical areas such as
the prefrontal cortex, a portion of the frontal cortex that is responsible for higher
order thinking and executive function broadening our understanding of memory
(28). Other cortical regions include areas known collectively as the
parahippocampal regions and include the entorhinal cortex and perirhinal cortex
(29,30).
Memory can be split into two categories, declarative and non-declarative. Nondeclarative memory includes information that is not consciously recalled, such as
emotional responses and habits, whereas declarative memory is recalled
consciously and includes facts and events (29). Episodic memory is a form of
declarative memory that encodes environmental and situational information of a
certain event. This type of memory is the “what, when, and where” of an event
(29).

5

Many studies have been conducted to determine exactly which brain regions
contribute to such memories in rodent models (31-36). Different behavioral
paradigms can be used to mimic events in a controlled setting. Rodent tasks
developed specifically to test single components of episodic memory are object
recognition (what), object in place (where), temporal order (when) (37). During
each task there is a sampling phase where the animal is allowed to explore the
environment with given objects in specific arrangements, two objects in object
recognition and temporal order and four objects in objects in place. For temporal
order only there is a second sampling phase with two new objects. Following a
period of memory retention, the animals are exposed to a test period where a
specific component of the task as been changed. For object recognition
(Schematic 1A), one of the objects as been replaced with a new object. The
order in which the animals saw the objects has been changed during test period
of temporal order (Schematic 1B), and finally, the location of two objects have
been switched during the testing phase of object in place (Schematic 1C). The
time the animal spends exploring the different object is considered the
recognition of that change in environment. Task descriptions can be found in
Schematic 1. Another task used to assess episodic memory is spatial location.
This task can involve allowing the animal to swim in a pool of water until they find
the platform on which they can escape and measures latency to find that platform
in subsequent trials. This task can also be performed using changes in object
location as well.
6

Using these methods, studies have been conducted using localized lesions to
damage specific brain areas to determine if these regions contribute to the
behavior being investigated. Historically, these studies focused on three key
areas in the brain, the hippocampus, the perirhinal cortex and the prefrontal
cortex (29-33). Damage to different areas leads to different performances by the
rodents in the varying tasks. These experiments demonstrated that all three
areas investigated were involved in recalling the “where” in the object-in-place
task and “when” of objects in temporal order task, but that only the perirhinal
cortex was necessary for the “what”, that is the recall of objects themselves (3435). Though these studies helped to indicate the involved brain regions, they do
not offer clues about how the different regions are communicating with one
another. Later studies, using optogenetic methods where special light-activated
channels control neuronal activation, were able to determine that glutamatergic
projections from the prefrontal cortex impact a rodent’s performance on an object
task but not object recognition (36). This study suggests that PFC-->PRH circuit
is not responsible for object recognition. Such findings prompt the need to
expand our knowledge about the circuitry underlying these types of memory.
Section 5: Methamphetamine, Episodic Memory and the Perirhinal Cortex
Rodents in models of methamphetamine addiction have shown deficits in
attention, impulsivity and episodic memory similar to what is seen in humans
(38). Following neurotoxic regimens of methamphetamine administration, rats
have been found to have decreases in recognition memory performance on
7

object recognition as well as object in place tasks but not in spatial location tasks
(39-43). Long access to meth-induced changes in object recognition memory
while short access meth self-administration did not (39). These investigations
showed behavioral and biochemical changes as a result of non-contingent and
binge doses of meth given to rats. Specifically, changes in monoamine
transporters were found in the PRH and HPC of animals that performed poorly
on object recognition memory and spatial memory tasks, respectively (40).
Such studies have directed work from the Reichel lab. The PRH has been shown
to be dysregulated following chronic methamphetamine in both a rodent long
access model as well as a binge non-contingent model of drug taking (41-44).
Long-access meth has been shown to decrease the natural proclivity of a rodent
to explore objects that are novel (44,45). Previous work from the Reichel Lab has
shown that chronic methamphetamine can lead to downregulation of
metabotropic glutamate receptor 5 expression(mGluR5) (45) and disruption of
long-term depression specifically in this region (46). Such meth-induced deficits
were restored by direct infusion of a mGluR5 positive allosteric modulator into the
PRH (45). Anatomically the PRH is connected to many other regions that have
been dysregulated in MUD including another region in the memory and addiction
circuitry, the PFC. The PFC has been shown to be a key player in addiction
biology (47) and the reciprocal connections in the rat PRH can be seen in
Schematic 2 (30). As this interplay of addiction and memory occurs in both the
PFC and the PRH it is important to determine if this circuitry plays a critical role in
8

object recognition behavior. I hypothesize that it is an intact projection from
the PRH to the PFC that is essential for object recognition and that this
pathway is damaged by chronic methamphetamine use. To determine the
involvement of the PFC and PRH during the task, the reciprocal connections will
be characterized following the task and the circuitry from PRH to PFC will be
manipulated during the NOR task using dual viral approach to activate or inhibit
the pathway.

9
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Chapter 2: Methods
Subjects: Age-matched male (250-275g) and female (225-250g) Sprague Dawley
rats (Envigo, Indianapolis, IN, USA) were used in the following experiments.
Viral Infusions: Animals were sedated at an appropriate anesthetic plane for
intracranial infusions using a Kopf digital stereotax. For experiments 1 and 2,
AAVrg-hSyn-HI-enhanced green fluorescent protein (eGFP)-Cre-WPRE-SV40
[71012vg/ml; Addgene#105540]) was infused into the PRH and PFC,
respectively. A dual viral approach was utilized in experiments 3 and 4, where
the viral construct above was infused into the PFC while Cre-dependent
DREADDs (Gq-DREADD: AAV2-hSyn-DIO-hM3D(Gq)-mCherry Addgene
#44361 or Gi-DREADD: AAV2-hSyn-DIO-hM4D(Gi)-mCherry Addgene #44362)
were infused into the PRH. Viral infusions were completed using a Nanoinject II
at a volume of 50.6 nl per injection every 30 s at a rate of 23 nl/second for a total
of 0.5 ul per hemisphere followed by an additional 5 min to allow the12njectted
virus to diffuse prior to removal of the pipette. Stereotaxic coordinates for all
intracranial surgeries are as follows, PFC: AP+2.8 mm; ML, ± 0.64 mm; DV –4.5
mm and PRH: AP –4.8mm; ML +5.0mm; DV –7.5mm at a -10° angle. Animals in
experiment 1,2, and 4 all underwent a period of viral incubation for three weeks
in the home cage. Animals in experiment 3 underwent methamphetamine selfadministration following surgeries.
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Novel Object Recognition: The NOR behavioral task was conducted using a
large circular arena (100cm in diameter) with walls constructed of poster paper
secured to the side of the arena via Velcro. Curtain walls were constructed
surrounding the arena to block outside environmental distractions with four soft
lights used within the curtained area. A camera with Ethovision software was
suspended above the arena for analysis of tasks. The behavioral task included
two days of habituation where each animal was allowed to explore only the arena
for 10 minutes. On the third day, animals underwent a 5-minute period of
sampling where they were exposed to two objects, either two curved PVC pipes,
or two travel shampoo bottles. Animals were returned to the home cage following
sampling for a retention period of 90 minutes, after which animals were returned
to the arena with one familiar object and one novel object counterbalanced for
placement. As a control in experiments 1 and 2, a subset of animals was only
exposed to familiar objects and were never shown a novel object. Videos of
sampling and test behavior were recorded with Ethovision software and manually
scored for object interaction. Interactions with objects were designated by nose
or front paw interactions. Animals climbing over the object were not scored as
interacting with object. Recognition index (RI) of novel object was determined by
the equation RI= Time spent with novel object/Total time with both objects.
Animals in experiment 3 or 4 were injected with 10 mg of clozapine-N-oxide
(CNO) or saline solution immediately after the sampling period.
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Catheter Surgery and Methamphetamine Self-Administration: Animals in only
experiment 3 underwent intravenous jugular catheterization for drug selfadministration following intracranial surgeries. These surgeries included sedation
at the same anesthetic plane as stereotaxic surgeries. Magnetic single port
catheters (SAI Infusion Technologies) were fed subcutaneously from the back of
the animal to the right jugular vein where they were secured into the vein by
sutures. Following recovery, these animals were placed in drug selfadministration chambers from MedPC and allowed to lever press for 6 hours per
day for 18 days on a fixed ratio of 1, where 1 lever press equated to 1 infusion of
meth at a dose of 0.4 mg/ml. Following SA, animals underwent a period of forced
home cage abstinence for 7 days.
Immunohistochemistry: Ninety minutes following NOR test period, all animals
were transcardially perfused, and brains were removed. Tissue was sliced on a
cryostat at 40-50um and were subjected to immunohistochemistry protocols for
amplification of GFP and c-FOS or GFP, c-FOS, and mCherry.
Microscopy and Analysis: Tissue was analyzed using both scanning laser
confocal and epifluorescent microscopy. Cells of interest were determined by colocalization of GFP and c-FOS in Experiments 1 and 2 and mCherry and c-FOS
in Experiments 3 and 4.
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Chapter 3: Tracing Activated Pathways during Object Recognition Memory
Section 1: Introduction
Chronic methamphetamine use in humans has been shown to cause memory
deficits, specifically in episodic memory. Episodic memory encodes the spatial
and contextual details of a given event. The brain regions responsible for this
type of memory have been found to be the triangulation of circuitry between the
medial prefrontal cortex, the perirhinal cortex and the hippocampus (31-36). Such
studies show the PRH to be the primary substrate in object recognition memory.
Though these studies have provided the broad regional input in episodic
memory, our knowledge base thus far lacks details pertaining to neuronal
activation following a memory task and information about the directionality of
such activation. In order to determine sources of neuronal input into the PRH and
PFC, I utilized an established method of virally induced neuronal tracing followed
by activation during a novel object recognition behavioral task. Neurons with
terminals located in brain regions of interest were visualized as the virus used
transduces at the axon terminal and is transported back to cell body where it is
expressed. This strategy was used to identify projections into the PRH or PFC
and allow for the understanding of which specific cells were activated during the
task.

15

Section 2: Results
For experiment 1, a retrograde AAV viral construct with enhanced GFP-tagged
CRE recombinase was infused into the PRH by stereotaxic surgery. Animals
were subjected to the NOR paradigm after three weeks of viral incubation. During
this task, animals were sorted into two groups as a control for neuronal activation
from sensory and motor cortices. One group was not exposed to a novel object
but rather two of the same objects, like in the sampling period. The second group
underwent a typical NOR setup. Animals from each group explored both objects
equally during sampling, also called familiarization, (Figure 1A, t (32) =0.2580,
p=0.7980, unpaired t-test). In a two-way interaction analyzing the time each
group spent with each object, animals that previously saw the same two objects
spent the same amount of time with both objects whereas animals in the second
group spent more time exploring a novel object than the same familiar object,
Figure 2B. The overall two-way ANOVA was significant F (1,15) =7.077,
p=0.0178. The main effect of object was significant F (1,15) =5.121, p=0.0389.
The main effect of group was not significant F (1,15) =0.0348, p=0.8545. Post
hoc Šídák multiple comparisons showed that the mean difference in time spent
between objects was only significantly different in the novel group (p=0.0032). In
Figure 1C, the recognition index of each group is defined as object exploration
above chance where the dotted line indicates interactions due to chance alone.
Animals that saw a novel object interacted with the object more than by chance
alone (Wilcoxon signed rank test, t (7) =5.712, p=0.0007) while the animals that
16

saw the same object did not (t (6) =0.3314, p=0.7516). Following the assay
outlined in the methods, animals were euthanized 90 minutes following the
behavior to ensure peak c-Fos expression (48). Native unamplified GFP was
imaged along with c-Fos following immunohistochemistry for expression patterns
in the PFC. Due to the anatomical nature of the projections outlined in Chapter 1
as well as possible differing actions of subregions, the PFC was further
separated into the prelimbic (PL) and the infralimbic (IL) for investigation. Cell
counts among the groups were all analyzed with two-tailed unpaired t-tests. GFP
in this experiment was used as a marker of viral transduction and was used to
normalize for viral transduction across groups. As such, the number of cells that
were Fos+GFP+ was normalized as a percentage of the total number of GFP+
cells in the region.
In the PL of the PFC there were no differences in the number of c-fos expressing
cells between animals that saw the familiar object and animals that saw the novel
object (two tailed unpaired t test; t (14) =0.3089, p=0.7620, Figure 2A). There
was no difference in the number of cells labeled with GFP between the groups
(two tailed unpaired t-test; t (14) =1.750, p=0.1019, Figure 2B). There was found
to be no difference in the number of cells with overlapping labeling of GFP and cfos between the groups as seen in Figure 2C (two-tailed unpaired t-test, t (14)
=1.386, p=0.1875). This profile persists when normalized to total GFP expression
in the region, there were no differences in the percent c-fos+GFP+ cells (two
tailed unpaired t test; t (14) =0.1151, p=0.9100, Figure 2D). Figure 2E shows
17

representative images of GFP and c-Fos-expressing cells from each group, the
yellow arrow indicates a co-labeled cell. A similar pattern of GFP and c-fos
expression was seen in the IL. In Figure 3A, c-fos expression was not found to
be different between animals that saw the familiar objects or the novel objects
(two-tailed unpaired t-tes, t (12) =0.6713, p=0.5148). The number of GFPcontaining cells did not differ between the two groups (two-tailed t-test, t (14)
=1.757, p=0.1008, Figure 3B). Unlike the PL, there was found to be a greater
number of co-labeled Fos+GFP+ cells in the IL of the animals that saw the novel
object versus those that did not (two-tailed t-test, t (13) =3.895, p=0.0018, Figure
3C). Once normalized, this effect was lost. There was no difference between
control and novel groups (two-tailed t-test, t (14) =0.1703, p=0.8672, Figure 3D).
Representative images of GFP and c-Fos expressing cells from each group in
the IL are shown in Figure 3E.
The same method was utilized to trace and determine the input into the PFC
during object recognition memory (Experiment 2). GFP-tagged retrograde AAV
virus was infused into the PFC via stereotaxic surgery. The virus was allowed to
incubate for at least 3 weeks. During familiarization or sampling, animals did not
explore one object more than the other (Figure 4A, two-tailed unpaired t-test,
t(26) =1.419, p=0.1678). The overall two-way ANOVA was not significant F (1,13)
=2.227, p=0.1595. The main effect of object was not significant F (1,13) =3.033,
p=0.1052. The main effect of group was significant F (1,13) =8.017 p=0.0142.
However, when compared to chance exploration, rats that saw novel objects had
18

significantly higher preference ratios indicating a preference for the novel object ,
Figure 4C (t (4) =4.838, p=0.0084, one-sample t and Wilcoxon test). Animals in
this experiment were euthanized following NOR for c-Fos analysis in PRH. There
was no difference in the number of c-Fos containing cells between animals in
novel and control groups (Figure 5A, two-tailed unpaired t-test, t (11) =1.527,
p=0.1550). A significant difference in the number of GFP labeled cells was found,
where there were more labeled cells in the control group (Figure 5B, t (12)
=3.197, p=0.0077) than in the test group. A significant difference between groups
of co-labeled Fos+GFP+ cells was not found (two-tailed unpaired t-test,
t(11)=0.6270, p=0.5434, Figure 5C), but when number of co-labeled cells was
normalized to the total number of cells expressing GFP, a significantly greater
number of co-labeled cells was found in animals that saw the novel object than in
animals than saw the same objects (unpaired t-test, t (11)=2.768, p=0.0183,
Figure 5D). Figure 5E shows the representative images of GFP and c-Fos
expressing cells from the PRH.
Section 3: Discussion
Previous work has suggested that episodic memory is the result of the
coordination of the PFC, HPC, and PRH regions of the brain. The behavioral
profiles for the animals were as expected showing that the task used exploits a
rat’s natural proclivity for exploring new objects in an environment. The control
group used in these studies also behaved as expected by investigating the same
two familiar objects equally. Using a retrograde viral tracer to map the inputs in
19

the PRH and activation following the NOR behavior showed that receiving inputs
in the PRH do not change when an animal is presented with a novel object
versus an object that has already been seen. The difference in the number of
Fos+GFP+ cells between animals that saw a novel object versus those that did
not was significant in the IL but not in the PL of the PFC. A lack of difference
between the groups suggests that circuitry from PFC to PRH does not direct
NOR behavior. Cell counts for the opposite direction, PRH-->PFC, did show a
difference between the two groups. Statistically, no differences were found
between the two groups in the number of Fos cells or Fos+GFP+ cells. The
difference between the groups is apparent after the normalization to total number
of GFP cells. The results indicate a greater percentage of Fos+GFP+ cells in the
PRH of the animals that saw the novel object compared to the control. This
normalization step became more important as a result of the significant
difference in the number of GFP+ cells with the control group expressing higher
numbers. As the groups were randomly assigned after surgeries and surgeries
were performed in a uniform manner across the cohort this is likely an
experimental artifact. However, the difference in the groups following
normalization suggests that the PRH-->PFC circuitry conducts the flow of
information in this task. That the PRH is the central substrate for object
recognition data is congruent with data from the lesion studies previously
published (31-36).
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Activated and tracer neurons did not overlap in every occurrence. This suggests
that only a subset of neurons in each brain region are involved in this task. This
method of viral tracing is not without its caveats. Though AAVs are often reliable
they do spread and are not always cell type specific. Cellular penetration is also
not always guaranteed therefore some cells may have undergone relatively less
transfection than others at time of testing. As mentioned earlier, in each region
visualized for inputs into the PFC, the GFP expression was greater in the control
group than in the novel group. This is perplexing since animals were randomly
assigned into groups after surgery therefore differences in viral transfection of the
retrograde tracer should not exist here. Some possible explanations are
inaccurate stereotaxic coordinates or complications with infusion instruments
resulting in different viral load having been injected into the control animals.
These experiments show that it is activation of the PRH and the communication
from the PRH to the PFC that is more imperative in this specific task as denoted
by the lack of significance in the number of co-labeled neurons in the PFC
following the behavior. This is further supported by the significant number of colabeled activated neurons in the PRH following the retrograde tracing from the
PFC.
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Chapter 4: Chemogenetic Manipulation of PRH-PFC Pathway in NOR
Section 1: Introduction
Changes in the PRH following chronic meth exposure contribute to the deficit
seen in recognition memory behavior in rodents. A technique used activate or
inactivate brain areas or circuits are designer receptors activated exclusively by
designer drugs (DREADDS). These receptors are mutated muscarinic
aceytlcholine, G protien coupled receptors that only have binding affinity with
specific ligands. The receptors are introduced in vivo by viral vectors. The
specific action on the infected cell is determined by the subunit coupled with the
G protein and can stimulate or inhibit a cell. The specific drug that has been used
to activate this type of virally transduced receptor, clozapine-N-oxide (CNO).
Chemogenetic activation of the PRH has been shown to restore object
recognition in the lab in a non-circuit specific manner (50). These previous
studies examined sole manipulation of PRH in the NOR task but not the circuitry
involved. DREADDS that are only expressed in the presence of CRE
recombinase can inform us about pathway specificity when manipulated in the
NOR task. The following experiments use an excitatory DREADD, where the
receptor is coupled with a Gq protein for activating the cell, and an inhibitory
DREADD, which is coupled with a Gi protein, for depressing activity in the cell.
The experiments below were used to determine whether object recognition could
be restored in animals that have a history of meth use and disrupted in methnaïve animals.
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Section 2: Results
Animals in experiment 3 underwent intracranial surgery to infuse a CREdependent Gq DREADD into the PRH and a retrograde CRE virus into the PFC.
Afterward, these animals were implanted with indwelling jugular vein catheters
for methamphetamine self-administration. Figure 7 shows the acquisition curve
over 18 days of SA. The overall two-way ANOVA was not significant F (17,233)
=1.138, p=0.3187. The main effect of day on intake was significant F (17,233)
=4.922, p<0.0001. The main effect of sex was not significant F (1,14=0.1289,
p=0.7250. Following 7 days of forced abstinence in the home cage, animals were
tested in the NOR paradigm. Animals equally explored both objects in the
sampling period (t (30) =1.425, p=).1643). The DREADD activating drug, CNO,
was given to animals immediately following sampling with two of the same
objects. During the testing phase, animals that received saline vehicle injection
did not significantly explore the novel object more than the familiar. Animals that
received the CNO injection explored the novel object, object B, significantly more
than the familiar object, object A. The overall two-way ANOVA was not significant
F (1,14) =1.832, p=0.1974. The main effect of object was significant F (1,14)
=11.77, p=0.0041. The main effect of group was not significant F (1,14) =0.4486,
p=0.5139. The group that received CNO injection had a recognition index
significantly above chance alone (t (7) =3.430, p=0.0110, one sample t and
Wilcoxon test), while vehicle animals did not (Figure 7C, one sample t and
Wilcoxon test, t (5) =0.9328, p= 0.3937). There was no difference in the
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recognition index between the groups in an unpaired t test. As in Experiment 1
and 2, animals were euthanized 90 minutes following behavioral testing for c-Fos
analysis. A difference in the number of mCherry, an indicator of DREADD
expression following CRE recombination, labeled cells were not found between
the groups injected with vehicle versus those injected with CNO (t (8) =0.6169,
p=0.5545, Figure 8A). There was also no difference in the number of co-labeled
cells for mCherry and c-fos between CNO and vehicle groups (two-tailed,
unpaired t-test, t (8) =2.196, p=0.0594). Similar to Experiments 1 and 2, the
number of mCherry expressing cells was used to normalize for viral transfection
so that when the number of co-labeled cells were expressed as a percentage of
the total number of mCherry cells, animals that received the CNO injection had a
greater number of co-labeled cells than those that received vehicle (two-tailed
unpaired t-test, t (7) =3.481, p=0.0103, Figure 8C). Figure 8D shows the relative
placements of viral infusions among the animals, differences in experimental
conditions are not shown. Figure 9 shows a representative overlay of mCherry
and c-fos expressing cells from an animal injected with CNO.
In experiment 4, an inhibitory DREADD was used instead of an excitatory
DREADD. Animals were intracranially infused with Gi DREADD in the PRH and a
retrograde CRE virus in the PFC to move back along the projections to the PRH.
These animals were housed in the home cage vivarium until they reached a
similar age to animals in Experiment 3. Animals in this experiment did not show
a difference in time spent with each object during sampling (Figure 10A, two29

tailed unpaired t-test, t (28) =0.5513, p=0.5858). As with Experiment 3, these
animals were injected with CNO immediately following the sampling phase. After
90 minutes retention animals were tested. The overall two-way ANOVA was not
significant F (1,12) =1.878, p=0.1956. The main effect of object was not
significant F (1,12) =3.262, p=0.0960. The main effect of group was not
significant F (1,12) =0.3629, p=0.5581. The group of animals that received an
injection of CNO activating the inhibitory DREADDS had a significantly lower
recognition index than due to chance alone (one sample t and Wilcoxon test, t (7)
=2.667, p=0.0321. While the group of animals that received a vehicle injection
did not have a recognition index significantly higher than chance alone (on
sample t and Wilcoxon test, t (5) =2.204, p= 0.0787) there was a significant
difference in the group recognition indices between the vehicle and CNO groups
(two-tailed unpaired t-test, t (12) =3.315, p=0.0031). There was no difference in
the number of mCherry or co-labeled Fos+mCherry+ expressing cells between
the two groups (Figure 11A and 11B two-tailed unpaired t-test, t (10) =1.444,
p=0.1792, t (10) =1.470, p=0.1724, respectively). When normalized to the total
percentage of mCherry expressing cells in the groups, there was a significant
decrease in the number of co-labeled cells in the group that received the CNO
injection in comparison to the group that received vehicle injection (Figure 11C,
two-tailed unpaired t-test, t (10) =2.002, p=0.0366). Figure 11D shows the
placement and general spread of the viral infusions into the PRH.
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Section 3: Discussion
The use of pathway-specific excitatory and inhibitory DREADDs in the PRH
during NOR produced the desired restoration and inhibition of recognition
memory respectively. Activating the pathway through Gq DREADDS reestablished object recognition memory in animals with a history of meth.
Inhibiting the pathway disrupted recognition memory to lower novel object
exploration than due to chance alone in rats that should otherwise be able to
distinguish novel from familiar. This again suggests that the PRH-->PFC circuitry
directs this behavior to indicate that there is something new and different about a
previously experienced environment. It is possible that following input from the
PRH, the PFC, the main hub for executive function, encode information about the
salience of that novelty but if the information about the existence of a novel
object is not received from the PRH the PFC cannot process whether the object
should be explored. Animals with the inhibitory DREADDS were meth naïve
animals so any impacts that meth could have on PFC are not present in these
animals. It is solely the inhibition of neurons that signal the PFC from the PRH
that resulted in the absence of recognition memory. Like experiment 3 where
dual vial approach with DREADDS was also used, unilateral expression of the Gi
DREADDS was found in some animals following tissue processing. Animals that
were found to have this unilateral expression still had recognition indices
indicative of a lack of novel object recognition. It is possible that the receptors
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were expressed at a threshold lower than what is necessary for detection with
the methods used, but still able to inhibit the pathway during the behavior.
As with the first set of experiments, the existence of some cells that express
mCherry or c-fos but not co-labeled suggests that only a subset of projection
neurons are involved in this particular behavior. As the PFC and PRH are also
involved in other aspects of episodic memory, determining if there are sets of
neurons for each component of episodic memory would be very important.
Additional subjects should be added to these studies to verify if the behavioral
profiles persist. Other controls that should be added to these data sets include
CNO and viral controls. Viral controls would ensure that the expression of foreign
proteins such as mCherry do not impact the function of the neurons or are
innately damaging enough to alter behavior. These animals could also be
injected with CNO at the same time point as the experimental animals in these
studies to ensure that the drug is inert in the brain when not in the presence of
DREADDS. Each of these controls can be used to determine if the viral vector or
drug has any off-target effects that could result in altered behavior.
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Chapter 5: Final Discussion
Section 1: Conclusions and Significance
The experiments described above indicate that circuitry between the PRH and
the PFC is indeed involved in object recognition memory. The first set of
experiments showed that, though there are reciprocal connections between
these brain regions, the PRH projection to the PFC is more involved than that of
the projection from the PFC to the PRH as demonstrated by the greater
difference in co-labeled activated cells. The second set of experiments further
showcases the importance of this unidirectional communication in object
recognition memory and how changes to the PRH can prevent the broadcast of
signals from the PRH to other brain regions. Excitation of the PRH-->PFC
circuitry restored novel object recognition following chronic meth SA, historically
seen to induce deficits, while inhibition of this circuitry resulted object recognition
deficits in naïve rats mimicking meth use.
Previous work conducted over the last few decades has shown that PFC, PRH,
and HPC are essential substrates for recognition memory (29-33). Specifically,
lesion studies have shown the necessity of an intact PRH in order for rodents to
reliably determine when an object is novel in a given environment (31-36). The
studies outlined here show that it is not just the PRH that is important but the
communication pathway from the PRH to the PFC that is important. Though this
fits within the previously held theories that the triangulation of PFC, PRH, HPC
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circuitry is the basis for recognition memory, the data from these studies
suggests that outward communication from the PRH to the PFC is responsible
for specifically object recognition memory.
The data presented suggests a broader role for brain regions receiving input from
the PRH than previously thought in objection recognition memory. Previously, it
has been understood that a novel object in a given environment triggers the
activation of the PRH alone and that processing of this information was thought
to occur here, leading to the exploration seen in the behavioral outcomes. Given
the current findings outlined, the PRH establishes recognition of novel objects in
a given environment directing exploration of these objects.
Section 2: Sex as a Biological Variable and Limitations
In the described studies, both male and female rats were used, though the data
was eventually collapsed between the sexes. This was due to the lack of
significant differences in the behavioral measures between the sexes. For novel
object recognition alone, these similarities are consistent with what has been
previously seen. Female rats have been observed to have higher amounts of
meth intake overall than males (50). No differences in intake were observed in
my experiments but only a small portion of represented animals received meth.
Given larger sample size it is possible that differences in drug intake could be
observed, but that the measures of object recognition would still be the equal
between the sexes following chronic exposure.
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Limitations with the experiments are that the overall sample size per group is low,
differences in viral transfection, and differences in tissue processing leading to
loss. Each experiment had 8-10 animals used at the beginning of each
experiment, but over the duration of the data collection, some samples were lost.
Though each surgical procedure conducted was kept as uniform in nature as
possible, minute changes in equipment and stereotaxic surgery could have
resulted in animal loss or differences in transfection of the virus. Given that the
results of these experiments were based in cell counts from viral expression this
had the potential to skew the results, thus prompting normalization steps. Though
the behavior was restored, the tissue collection following experiments showed
that several animals had unilateral expression of DREADDS, indicated by
mCherry fluorescence. This suggests that only one pathway was available for
activation. This data is congruent with previous lesion studies that indicate that
only one intact PRH was needed for object recognition.
Section 3: Future Directions
Through the circuitry approach, projections between the PRH and PFC were
identified though not all were found to be involved in NOR behavior. Further
characterization of the specific group of neurons involved and the impact chronic
meth can have on them is needed. Future areas of investigation could include
determining which region, PRH or PFC, is involved in the salience of the novel
objects or the role of the projections from other regions, such as the PVT, in NOR
behavior following chronic meth.
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Object recognition memory is reliant on an intact pathway from PRH-->PFC. The
PRH and its projections are damaged as a result of chronic meth use. Loss of
episodic memory such as recognition memory is prevalent in abstinent and
recently relapsed human users of meth (18). As such this is a potential target for
enhancement to prevent future relapse events.
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Appendix A: Brain Regions Projecting to PRH
As activation mapping of NOR behavior is limited, a cursory look of other brain
regions containing GFP and c-fos labeled cells was conducted from subsets of
whole brain. Other regions found to project to the PRH include the
paraventricular thalamus, ventral subiculum and CA1 of the hippocampus.
These structures included portions of the HPC, an expected locale, but also the
PVT. The PVT acts as a relay station for rewarding and threatening responses to
stimuli (51). The arena used for this task was large and relatively open with the
objects in the center. Given that rats do not naturally like to spend time in open
spaces that can leave them vulnerable to predator attack, the activation of the
PVT in this context are understandable. Cell count data can be found in
Appendix Figures 1-3 below for PRH inputs.
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Appendix B: Brain Regions Projecting to PFC

Other regions of activation following NOR task with projections to the PFC were
investigated. These regions were found to include the BLA, PVT, and vSub of the
HPC. The BLA was activated in animals that saw the novel object, with a greater
number of c-Fos+ cells than those that saw the familiar object (Appendix B,
Figure 1). The PVT acts as a relay station for rewarding and threatening
responses to stimuli (44) while the amygdala is the central substrate to process
fearful stimuli (45). The arena used for this task was large and relatively open
with the objects in the center. Given that rats do not naturally like to spend time in
open spaces that can leave them vulnerable to predator attack, the activation of
the PVT and the BLA in this context are understandable. Because both regions
project to the PFC, the final determination to investigate the object could be
processed here. Each region was imaged for GFP expression and c-FOS though
none showed significant differences among the groups following normalization.
Cell count data can be found in Appendix B Figures 1-3 for the PFC inputs.
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